2024 annual financial data
Skye Bioscience 2024 Operating margin
Skye Bioscience 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -30,192,718 USD and net income was -26,567,123 USD.
Operating cash flow was -25,237,480 USD.
Get free Skye Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -30,192,718 USD
- Net income
- -26,567,123 USD
- Operating cash flow
- -25,237,480 USD